Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2008-12-09
Original market date: See footnote 1
1997-02-01
Product name:
MUTACOL
DIN:
02229525
Product Monograph/Veterinary Labelling:
Date:
2002-04-29
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BERNA BIOTECH LTD
Rehhagstrasse 79
Bern
Bern
Switzerland
3018
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
SCHEDULE D
American Hospital Formulary Service (AHFS): See footnote 3
80:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
J07AE02 CHOLERA, LIVE ATTENUATED
Active ingredient group (AIG) number:See footnote5
0133249001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| CHOLERA VACCINE, LIVE ORAL CVD 103-HGR | 1000000000 CFU / DOSE |